Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes Pilot Study

NCT07868666 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT07868666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07868666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes Pilot Study
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
October 31, 2032
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney diseases, sglt2 inhibitor use, type 2 diabetes mellitus